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20. L. G. Marshall, Am. Sci. 76, 380 (1988 T he serotonin system plays a key modulatory role in a plethora of functions of the central nervous system in physiological and disease states (1, 2) . Compounds that alter either the reuptake or the metabolism of serotonin are used as medications against many neuropsychiatric disorders (1-4). A better understanding of the role of individual serotonin receptors in mediating the effects of these medications would improve our comprehension of the etiology of certain neuropsychiatric disease states and enhance our ability to design more effective medications. There are 14 different serotonin receptors (2), some of which have multiple splice variants that enable binding of distinct sets of intracellular proteins (5). 5-HT 1B receptors play a crucial role in regulating serotonin neurotransmission, as they serve as both autoreceptors on serotonin-containing neurons originating from the raphe nuclei and heteroreceptors on several neurons that do not (6, 7) . Pharmacologic and genetic studies have suggested a role for 5-HT 1B receptors in the pathophysiology of obsessive compulsive disorder, drug addiction, depression, anxiety, aggression, and sleep (1, 7, 8) .
To better understand the function of 5-HT 1B receptors, we used the third intracellular loop of this receptor as bait in a yeast two-hybrid 
chain, and annexin II light chain), a member of the S100 EF-hand protein family (10) . p11 interacted with 5-HT 1B receptors, but not with 5-HT 1A , 5-HT 2A , 5-HT 5A , 5-HT 6 , dopamine D 1 or D 2 receptors, two irrelevant baits (CD115 and pRP21), or the empty plasmid, which showed the specificity of this interaction (Fig. 1A) . p11 was found to coimmunoprecipitate with 5-HT 1B receptors in HeLa cells and brain tissue (Fig. 1B) . Immunofluorescence studies showed a prominent colocalization between p11 and 5-HT 1B receptors at the cell surface (Fig. 1C) . The distribution of p11 mRNA in the brain resembled that of 5-HT 1B receptor mRNA (Fig. 1D) .
Long-term administration of the tricyclic antidepressant imipramine (Fig. 2A) , but not of haloperidol, risperidone, or diazepam (þ6, þ3, and þ1% versus saline), increased the amount of p11 mRNA (þ30 T 5% versus saline) in cortex. This effect of imipramine was restricted to the forebrain, e.g., it did not occur in the raphe nuclei (-3% versus saline).
In subsequent experiments, long-term administration of another antidepressant, tranylcypromine (þ29 T 4% versus saline; P G 0.05 Student_s t test), and repeated electroconvulsive therapy (Fig. 2B ) also increased the amounts of p11 mRNA in cortex. Moreover, imipramine and electroconvulsive therapy increased p11 protein in cortex ( fig. S1 ). The amounts of p11 were compared in helpless H/Rouen mice, a genetic animal model of depression, and nonhelpless NH/Rouen mice (11) . The amounts of p11 mRNA (Fig.  2C) and protein (fig. S1) were markedly reduced in H/Rouen mice. We also found down-regulated p11 mRNA (Fig. 2D) and protein ( fig. S1 ) in the anterior cingulate cortex in patients who had suffered from unipolar major depression disorder.
p11 regulates the translocation of annexin II and ion channels (NaV1.8, TASK-1, TRP5/6) to the cell surface (12) (13) (14) (15) . Likewise, COS-7 cells cotransfected with 5-HT 1B receptors and p11 exhibited more 5-HT 1B receptors at the cell surface than cells transfected only with 5-HT 1B receptors (Fig. 3A) . In contrast, the ratio of surface-to-total dopamine D 1 receptors was similar in the absence or presence of p11 (100 T 7.4 versus 103 T 13.0). We determined whether cotransfection with p11 would enhance the signaling efficacy of 5-HT 1B receptors, which are negatively coupled to adenylyl cyclase. Serotonin counteracted forskolin-induced adenosine 3 ¶,5 ¶-monophosphate (cAMP) formation more efficiently in COS-7 cells expressing both 5-HT 1B receptors and p11 than in cells expressing only 5-HT 1B receptors (Fig. 3B) .
Because antidepressant treatments elevated p11, we investigated whether increased amounts of p11 would affect behaviors relevant to antidepressant drug action. Transgenic mice with doxycycline-regulatable overexpression of p11 under the calcium/ calmodulin-dependent protein kinase II (CamKII) promoter were generated. In the absence of doxycycline, transgenic mice had elevated p11 in neurons that do not contain serotonin in the forebrain, but not in serotonin neurons in the raphe nuclei ( fig. S2 ). These mice had increased functional 5-HT 1B receptors in substantia nigra ( fig. S3 ) and exhibited reduced thigmotaxis (an index of anxiety-related distress) (Fig. 3C ) and increased horizontal activity ( fig. S4 ) in the open-field test. They also showed a decreased immobility in the tail suspension test (an index of depression-like state) (Fig. 3D) . Thus, mice overexpressing p11 acted as if they were treated with antidepressants, although a confounding factor was that they appeared to be generally hyperactive. Transgenic mice treated with doxycycline had normalized p11 expression ( fig. S4 ) and no significant alterations of thigmotaxis (Fig.  3C), immobility (Fig. 3D) , or horizontal activities ( fig. S4) .
We also generated p11 knockout (KO) mice ( fig. S5 ). Autoradiographic ligandbinding experiments showed that there were fewer binding sites for the 5-HT 1B receptor antagonist radioligands E 125 I^iodocyanopindolol ( Fig. 4A; fig. S6 ) and E 3 H^GR125743 ( fig. S6 ) in globus pallidus in p11 KO than in wildtype mice. Similarly, E 125 I^iodocyanopindolol binding was lower in substantia nigra pars reticulata in p11 KO than in wild-type mice (77.3 T 5.8 versus 98.8 T 6.2 fmol/mg protein; P G 0.05 Student_s t test). There was no difference in the affinity of serotonin to displace bound E 125 I^iodocyanopindolol between wild-type and p11 KO mice Emedian effective concentration (EC 50 ) values: 57 versus 52 nM). No differences in the amounts of 5-HT 1A , D 1 , or D 2 receptors were detected between the wild-type and p11 KO mice ( fig.  S6 ). E 125 I^Iodocyanopindolol binding was also reduced in H/Rouen mice versus NH/Rouen mice ( fig. S7) .
The reduced number of 5-HT 1B receptors at the cell membrane in p11 KO mice was reflected in a reduced ability of the 5-HT 1B receptor agonist anpirtoline (16) to increase E 35 S^guanosine 5 ¶-O-(3 ¶-thiotriphosphate (GTPg-S) binding in globus pallidus in these mice (Fig. 4B) . In contrast, there was no difference in E 35 S^GTP-g-S binding by 8-OH-DPAT E(þ/-)-8-hydroxy-2-(di-n-propylamino) tetralin^, a 5-HT 1A receptor agonist, in wild-type and p11 KO mice (6.0 T 2.1 versus 5.0 T 2.0 optical density units). The decreased number of functional 5-HT 1B receptors at the cell surface of p11 KO mice was also reflected in a loss of ability of serotonin and of anpirtoline to down-regulate phospho-Thr 202 /Tyr 204 -ERK1/2 (extracellular signal-regulated kinase) levels in primary cortical cultures from p11 KO mice (Fig. 4C) and of anpirtoline to decrease phospho-Ser 9 -synapsin I, a site phosphorylated by cAMPdependent protein kinase, in striatal slices from p11 KO mice (Fig. 4D) .
Serotonin, via 5-HT 1B receptors, reduces glutamate release at terminals of neurons originating from the cerebral cortex and inhibits synaptic transmission at corticostriatal synapses (17) . We monitored the amplitude of field excitatory postsynaptic potentials (f EPSPs) evoked by brief electrical stimulation of glutamatergic fibers and recorded extracellularly in the nucleus accumbens. f EPSPs were mediated by AMPA receptors activated by endogenous glutamate released by electrical stimulation of the slice in both wildtype and p11 KO mice Ef EPSP/population spike (PS) reduction 77 and 81%, respectively, compared with baseline, 15 min after the AMPA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX)^. When applied in the perfusion solution, serotonin depressed the amplitude of the f EPSP/PS in slices from wild-type, but not from p11 KO, mice (Fig. 4E) .
5-HT 1B receptors act as autoreceptors and inhibit serotonin release (2, 7). Because p11 is expressed in the raphe nuclei, the amounts of serotonin and its major metabolite 5-hydroxyindoleacetic acid (5-HIAA) were measured in projection areas, namely, cortex, striatum, and hippocampus in wildtype and p11 KO mice. In accordance with a negative regulation of 5-HT turnover and/or metabolism by 5-HT 1B receptors, and a potentiating role of p11 on 5-HT 1B receptor function, p11 KO mice have increased levels of serotonin turnover and/or metabolism (Fig. 4F) .
To evaluate behavioral effects of p11 deletion, we compared thigmotaxis in wildtype and p11 KO mice under basal conditions and in response to anpirtoline in drug-naBve mice and in mice that had been treated longterm with imipramine. In animals treated with imipramine, anpirtoline caused a significant reduction in thigmotaxis in wild-type mice, but not in p11 KO mice (Fig. 4G ). In addition, there was less thigmotaxis in saline-injected wild-type than p11 KO mice (Fig. 4G) . DrugnaBve wild-type and p11 KO mice exhibited similar thigmotaxis either in the absence or presence of anpirtoline. There was an increased immobility in the tail suspension test in p11 KO mice compared with wild-type mice, both under baseline conditions and after acute treatment with either anpirtoline or imipramine (Fig. 4H) . These behavioral results indicate that p11 KO mice exhibit a depressionlike phenotype and that p11 mediates behavioral responses to imipramine via 5-HT 1B recep-on February 5, 2009 www.sciencemag.org tors. In further support of a depression-like phenotype of p11 KO mice, we found that p11 KO mice consumed less of a palatable 2% sucrose solution than their wild-type littermates (1.74 T 0.07 versus 2.17 T 0.11 ml/g body weight per day; P G 0.05 Student_s t test), which indicated a decreased responsiveness to sweet reward. Water intake was similar in the p11 KO mice and their wildtype littermates (1.51 T 0.05 versus 1.42 T 0.05 ml/g body weight per day), which ruled out a role of altered fluid balance in this behavior.
Taken together, the results of the present study indicate that the dynamic modulation of 5-HT 1B receptor function by p11 may be involved in molecular adaptations occurring in neuronal networks that are dysfunctional in depression-like states.
